Nembutal Pentobarbital Sodium solution

    Available Forms

    Nembutal Solution(Injectable) 
    Nembutal Powder
    Nembutal Oral solution(Sterile)
    Nembutal Oral Solution(Non-sterile)

    Nembutal Powder
    12 grams
    15 grams
    20 grams 
    25 grams

    50 ml
    100 ml
    250 ml 
    300 ml


    Storage: Exposure of pharmaceutical products to heat should be minimized.Avoid excessive heat. Protect from freezing. It is recommended that the product can be stored at 20-25°C (68-77°F), however, brief excursions are permitted between 15-30°C (59-86°F). 


Price: $

NEMBUTAL Sodium Solution (pentobarbital sodium injection) is a sterile solution for intravenous or intramuscular injection. Each mL contains pentobarbital sodium 50 mg, in a vehicle of propylene glycol, 40%, alcohol, 10% and water for injection, to volume. The pH is adjusted to approximately 9.5 with hydrochloric acid and/or sodium hydroxide.

Indications and Usage



Hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks (See " Clinical Pharmacology " section).


Anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics.


Barbiturates are contraindicated in patients with known barbiturate sensitivity. Barbiturates are also contraindicated in patients with a history of manifest or latent porphyria.


Habit forming:   

Barbiturates may be habit-forming. Tolerance, psychological and physical dependence may occur with continued use. (See " Drug Abuse and Dependence " and " Pharmacokinetics " sections). Patients who have a psychological dependence on barbiturates may increase the dosage or decrease the dosage interval without consulting a physician and may subsequently develop a physical dependence on barbiturates. To minimize the possibility of overdosage or the development of dependence, the prescribing and dispensing of sedative-hypnotic barbiturates should be limited to the amount required for the interval until the next appointment. Abrupt cessation after prolonged use in the dependent person may result in withdrawal symptoms, including delirium, convulsions, and possibly death. Barbiturates should be withdrawn gradually from any patient known to be taking an excessive dosage over long periods of time. (See " Drug Abuse and Dependence " section).

IV administration:   Too rapid administration may cause respiratory depression, apnea, laryngospasm, or vasodilation with 
fall in blood pressure.

Acute or chronic pain: Caution should be exercised when barbiturates are administered to patients with acute or chronic pain because paradoxical excitement could be induced or important symptoms could be masked. However, the use of barbiturates as sedatives in the postoperative surgical period and as adjuncts to cancer chemotherapy is well established.

Use in pregnancy: Barbiturates can cause fetal damage when administered to a pregnant woman. Retrospective, case-controlled studies have suggested a connection between the maternal consumption of barbiturates and a higher than expected incidence of fetal abnormalities. Following oral or parenteral administration, barbiturates readily cross the placental barrier and are distributed throughout fetal tissues with highest concentrations found in the placenta, fetal liver, and brain. Fetal blood levels approach maternal blood levels following parenteral administration.

Withdrawal symptoms occur in infants born to mothers who receive barbiturates throughout the last trimester of pregnancy. (See " Drug Abuse and Dependence " section). If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
Synergistic effects:   The concomitant use of alcohol or other CNS depressants may produce additive CNS depressant effects.


The toxic dose of barbiturates varies considerably. In general, an oral dose of 1 gram of most barbiturates produces serious poisoning in an adult. Death commonly occurs after 2 to 10 grams of ingested barbiturate. Barbiturate intoxication may be confused with alcoholism, bromide intoxication, and with various neurological disorders.

Acute overdosage with barbiturates is manifested by CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may show paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

In extreme overdose, all electrical activity in the brain may cease, in which case a "flat" EEG normally equated with clinical death cannot be accepted. This effect is fully reversible unless hypoxic damage occurs. Consideration should be given to the possibility of barbiturate intoxication even in situations that appear to involve trauma.

Buy Nembutal Sodium solution Online

Nembutal liquid is of the best quality and convenient prices at Nembutal best suppliers.

Nembutal liquid is a drug that was also used during the 1940s as well as 1950s as a sleeping pill or an anti-anxiety drug.

The Nembutal liquid acts as an easy metabolism in the liver. Nembutal liquid is most commonly used nowadays in hospitals and we have the best of services to ship it to them too.And for a brief information to our clients, they should know that a massive liquid oral overdose would rapidly lead to a sufficient blood concentration to enable CNS and respiratory depression.

And is recommended as it is observed in some cases that a particular amount of Nembutal may be lethal for one and the same amount of the Nembutal may not be lethal for the other so one needs to be careful and specific) about the amount the client wants to buy for euthanasia.

Related Product

© 2017 All rights reserved.